Financial Times recently reported that Samsung South Korea plans to launch generic samsung-mobile version of a biological medicines by 2015 at half the price of the current Western prices. It claims that Samsung is gearing up to challenge the US and European pharmaceutical companies. It was stated that: The new production facility would be operated [...]